Babesia-And-Malaria-Free.Pdf
Total Page:16
File Type:pdf, Size:1020Kb
An Extensive Collection of Academic References Focused on Emerging Babesia and Malaria Treatment Options Citations on Current and Emerging Treatment Science for Researchers James Schaller, MD, MAR and Kimberly Mountjoy, MS ii Schaller • Mountjoy International University Infectious Disease Press Bank Towers • Newgate Center (305) 5150 Tamiami Trail North [Highway 41] Naples, Florida 34103 Copyright © 2012 James Schaller, MD All rights reserved. Cover Art: Nick Botner Lead Research and Research Study Acquisitions: Randal Blackwell Copy Editing by Kimberly Mountjoy, Lindsay Gibson, Jeremy Schaller and anonymous patients from all over the world Wholesale discount requires purchase of at least twenty copies and can be in five book units. Fax request to (239) 304-1987 and (239) 263-6760. Library of Congress Cataloging Data Schaller, J.L; Mountjoy, K. ISBN: 9780984088980 An extensive collection of academic references focused on emerging babesia and malaria treatment options : citations on current and emerging treatment science for researchers / J.L. Schaller and K. Mountjoy. 1. Babesia 2. Malaria 3. Research 4. Treatments 5. References Manufactured in the United States of America First Edition 10 9 8 7 6 5 4 3 2 1 Front cover images courtesy of the Centers for Disease Control An Extensive Collection of Academic References Focused on Emerging Babesia and Malaria Treatment Options iii To my beloved friends in USA prisons— Mike, Wayne, James, Bone C., Thaddeus, Julio and so many others— with a hope we will end our leadership as the PRISON NATION, and lead in liberty and not inmate numbers. Let our nation return to timely trials, end cruel and unusually excessive sentences, allow the poor to have a good defense, and may our peace officers never exceed the facts. Let our prisons never have any element of torture— the time is already a torture. And to all my many children, some by blood and some by care. Parenting is impossible, but I never favored the easy road. Thank you for making life so meaningful. Contents Introduction ................................................................................................. 1 Bibliography .............................................................................................. 3 Dr. Schaller’s Publications ..................................................................... 313 Other Books by Dr. Schaller .................................................................. 314 Disclaimer .............................................................................................. 328 Contacting Dr. Schaller .......................................................................... 329 An Extensive Collection of Academic References Focused on Emerging Babesia and Malaria Treatment Options 1 Introduction I have been studying Babesia and malaria treatments almost full-time for many years. While we have agents for treating malaria we still have many issues that limit application of effective care throughout the world. In contrast, research on Babesia is not very advanced and treatment op- tions are overly simplistic. Some researchers and clinicians feel one can simply plug in a malaria treatment with the same dose and duration, and get the same effect in killing Babesia. I am certain this is an error. If Ba- besia was “just like” malaria, we would call it a sub-type of malaria. Further, the number of true experts on Babesia, and who have read most of the publications in English print, is possibly under a dozen individuals. And yet with new issues with Babesia resistance and delivery of malaria care and new unique protozoa like FL1953, we see materials speaking with authority not based on broad scientific curiosity, but a type of sim- plistic medicine consistent with an emerging infection. Finally, Babesia has huge impacts in human biochemistry, hormones, weight, energy, sensations, tissue and organs. You cannot do one test and determine if Babesia is present in either an animal or a human. I wish such a comfortable myth was true, but it is just old and ineffective medicine. The references that follow are a small sample of materials related to treat- ment. This book is written for individuals who have a master’s degree, a PhD or MD in the medical sciences. If you are not trained at least at the master’s level in mammalian related science, this text is not for you. An Extensive Collection of Academic References Focused on Emerging Babesia and Malaria Treatment Options Citations on Current and Emerging Treatment Science for Researchers An Extensive Collection of Academic References Focused on Emerging Babesia and Malaria Treatment Options 5 Abanyie FA, Arguin PM, Gutman J. State of malaria diagnostic testing at clinical laboratories in the United States, 2010: a nationwide survey. Malar J. 2011 Nov 10;10:340. PMID:22074250 Abba K, Deeks JJ, Olliaro P, Naing CM, Jackson SM, Takwoingi Y, Donegan S, Garner P. Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries. Cochrane Database Syst Rev. 2011 Jul 6;(7):CD008122. PMID:21735422 Abbas HM, Brenes RA, Ajemian MS, Scholand SJ. Successful conservative treatment of spontaneous splenic rupture secondary to Babesiosis: a case report and literature review. Conn Med. 2011 Mar;75(3):143-6. PMID:21500704 Abdalla HS, Hussein HS, Kreier JP. Babesia rodhaini: passive protection of mice with immune serum. Tropenmed Parasitol. 1978 Sep;29(3):295- 306. PMID:726044 Abdulla S, Sagara I. Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children. Malar J. 2009 Oct 12;8 Suppl 1:S7. PMID:19818174 Abebe G, Kiros M, Golasa L, Zeynudin A. Schistosoma mansoni infection among patients visiting a health centre near Gilgel Gibe Dam, Jimma, south western Ethiopia. East Afr J Public Health. 2009 Dec;6(3):300-2. PMID:20803923 Abebe G, Kiros M, Golasa L, Zeynudin A. Schistosoma mansoni infection among patients visiting a health centre near Gilgel Gibe Dam, Jimma, south Western Ethiopia. East Afr J Public Health. 2010 Mar;7(1):78-80. PMID:21413578 Ablordeppey SY, Hufford CD, Borne RF, Dwuma-Badu D. 1H-NMR and 13C-NMR Assignments of Cryptolepine, A 3:4-Benz-delta- carboline Derivative Isolated from Cryptolepis sanguinolenta. Planta Med. 1990 Aug;56(4):416-7. PMID:17221441 6 Schaller • Mountjoy Aboulaila M, Nakamura K, Govind Y, Yokoyama N, Igarashi I. Evaluation of the in vitro growth-inhibitory effect of epoxomicin on Babesia parasites. Vet Parasitol. 2010 Jan 20;167(1):19-27. Epub 2009 Oct 3. PMID:19896277 Aboulaila M, Yokoyama N, Igarashi I. Inhibitory effects of (-)-epigallocatechin-3-gallate from green tea on the growth of Babesia parasites. Parasitology. 2010 Apr;137(5):785-91. Epub 2009 Dec 22. PMID: 20025823 AbouLaila M, Sivakumar T, Yokoyama N, Igarashi I. Inhibitory effect of terpene nerolidol on the growth of Babesia parasites. Parasitol Int. 2010 Jun;59(2):278-82. Epub 2010 Feb 21. PMID:20178862 Abrams Y. Complications of coinfection with Babesia and Lyme disease after splenectomy. J Am Board Fam Med. 2008 Jan-Feb;21(1):75-7. PMID:18178707 Abubucker S, Martin J, Taylor CM, Mitreva M. HelmCoP: an online resource for helminth functional genomics and drug and vaccine targets prioritization. PLoS One. 2011;6(7):e21832. Epub 2011 Jul 8. PMID:21760913 Adams LG, Todorovic RA. The chemotherapeutic efficacy of imidocarb dihydrochloride on concurrent bovine anaplasmosis and babesiosis. I. The effects of a single treatment. Trop Anim Health Prod. 1974 May;6(2):71-8. PMID:4416121 Adams LG, Todorovic RA. The chemotherapeutic efficacy of imidocarb dihydrochloride on concurrent bovine anaplasmosis and babesiosis. II. The effects of multiple treatments. Trop Anim Health Prod. 1974 May;6(2):79-84. PMID:4416122 Adan GL. Development of malaria control in the Philippines. J Philipp Med Assoc. 1954 Jan;30(1):29-35. PMID:13143503 An Extensive Collection of Academic References Focused on Emerging Babesia and Malaria Treatment Options 7 Adaszek Ł, Górna M, Krzysiak M, Adaszek M, Garbal M, Winiarczyk S. Identification of the piroplasms isolated from horses with clinical piroplasmosis in Poland. Wiad Parazytol. 2011;57(1):21-6. PMID:21634230 Adaszek Ł, Martinez AC, Winiarczyk S. The factors affecting the distribution of babesiosis in dogs in Poland. Vet Parasitol. 2011 Sep 27;181(2-4):160-5. Epub 2011 Apr 12. PMID:21524856 Adaszek Ł, Winiarczyk S, Górna M. [From piroplasmosis to babesiosis- -problems with classification of Babesia protozoa isolated from dogs]. [Article in Polish]. Wiad Parazytol. 2010;56(2):111-5. PMID:20707294 Adaszek Ł, Winiarczyk S, Skrzypczak M. The clinical course of babesiosis in 76 dogs infected with protozoan parasites Babesia canis canis. Pol J Vet Sci. 2009;12(1):81-7. PMID:19459444 Adaszek Ł, Winiarczyk S. [Dogs babesiosis--still actually problem].[Article in Polish]. Wiad Parazytol. 2008;54(2):109-15. PMID:18702315 Adebayo JO, Krettli AU. Potential antimalarials from Nigerian plants: a review. J Ethnopharmacol. 2011 Jan 27;133(2):289-302. Epub 2010 Nov 18. PMID:21093570 Adedotun AA, Morenikeji OA, Odaibo AB. Knowledge, attitudes and practices about malaria in an urban community in south-western Nigeria. J Vector Borne Dis. 2010 Sep;47(3):155-9. PMID:20834085 Aderinboye O, Syed SS. Congenital babesiosis in a four-week- old female infant. Pediatr Infect Dis J. 2010 Feb;29(2):188. PMID:20118748 Aditya NP, Patankar S, Madhusudhan B. Assessment of in vivo antimalarial activity of rifampicin, isoniazide, and ethambutol combination therapy. Parasitol Res. 2010 May;106(6):1481-4.